AVROBIO Balance Sheet Health
Financial Health criteria checks 6/6
AVROBIO has a total shareholder equity of $94.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $101.1M and $6.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$98.02m |
Equity | US$94.74m |
Total liabilities | US$6.35m |
Total assets | US$101.09m |
Recent financial health updates
Here's Why We're Watching AVROBIO's (NASDAQ:AVRO) Cash Burn Situation
Nov 13We're Keeping An Eye On AVROBIO's (NASDAQ:AVRO) Cash Burn Rate
Aug 10Here's Why We're Not Too Worried About AVROBIO's (NASDAQ:AVRO) Cash Burn Situation
Mar 08We Think AVROBIO (NASDAQ:AVRO) Can Afford To Drive Business Growth
Nov 23Recent updates
Avrobio rises as gene therapy for Gaucher disease gets ILAP designation in UK
Oct 18Avrobio stock rises as kidney disease gene therapy gets FDA rare pediatric disease status
Sep 20AVROBIO granted FDA’s orphan drug designation for metabolic disorder therapy
Jul 13Here's Why We're Watching AVROBIO's (NASDAQ:AVRO) Cash Burn Situation
Nov 13We're Keeping An Eye On AVROBIO's (NASDAQ:AVRO) Cash Burn Rate
Aug 10AVROBIO: Fabrazyme's Full Approval Changes Things
May 05Here's Why We're Not Too Worried About AVROBIO's (NASDAQ:AVRO) Cash Burn Situation
Mar 08AVROBIO: Undercovered Gene Therapy Developer With Excellent Promise
Dec 25We Think AVROBIO (NASDAQ:AVRO) Can Afford To Drive Business Growth
Nov 23AVROBIO readies $75M equity offering
Nov 19AVROBIO EPS misses by $0.19
Nov 05Financial Position Analysis
Short Term Liabilities: AVRO's short term assets ($100.3M) exceed its short term liabilities ($6.4M).
Long Term Liabilities: AVRO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: AVRO is debt free.
Reducing Debt: AVRO had no debt 5 years ago.
Debt Coverage: AVRO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: AVRO has no debt, therefore coverage of interest payments is not a concern.